Authors:
Romero, P
Dutoit, V
Rubio-Godoy, V
Lienard, D
Speiser, D
Guillaume, P
Servis, K
Rimoldi, D
Cerottini, JC
Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S
Authors:
Pittet, MJ
Speiser, DE
Lienard, D
Valmori, D
Guillaume, P
Dutoit, V
Rimoldi, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S
Authors:
Rubio-Godoy, V
Dutoit, V
Rimoldi, D
Lienard, D
Lejeune, F
Speiser, D
Guillaume, P
Cerottini, JC
Romero, P
Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307
Authors:
Dietrich, PY
Walker, PR
Quiquerez, AL
Perrin, G
Dutoit, V
Lienard, D
Guillaume, P
Cerottini, JC
Romero, P
Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054
Authors:
Dutoit, V
Rubio-Godoy, V
Dietrich, PY
Quiqueres, AL
Schnuriger, V
Rimoldi, D
Lienard, D
Speiser, D
Guillaume, P
Batard, P
Cerottini, JC
Romero, P
Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856
Authors:
Pinilla, C
Rubio-Godoy, V
Dutoit, V
Guillaume, P
Simon, R
Zhao, YD
Houghten, RA
Cerottini, JC
Romero, P
Valmori, D
Citation: C. Pinilla et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, CANCER RES, 61(13), 2001, pp. 5153-5160
Authors:
Rimoldi, D
Rubio-Godoy, V
Dutoit, V
Lienard, D
Salvi, S
Guillaume, P
Speiser, D
Stockert, E
Spagnoli, G
Servis, C
Cerottini, JC
Lejeune, F
Romero, P
Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261
Authors:
Valmori, D
Dutoit, V
Lienard, D
Lejeune, F
Speiser, D
Rimoldi, D
Cerundolo, V
Dietrich, PY
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538
Authors:
Valmori, D
Dutoit, V
Lienard, D
Rimoldi, D
Pittet, MJ
Champagne, P
Ellefsen, K
Sahin, U
Speiser, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506